Delivery Order SPE2DB20D2104-SPE2DB25FMYWG
- Not listed
- The Defense Logistics Agency awarded a $13,817.08 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This competitively awarded, firm fixed price contract was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $4,714.17 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This non-competitive, firm fixed price delivery order was awarded on September 18, 2025, with an ultimate completion date of September 19, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $12,202.67 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order was awarded on July 24, 2025, with a completion date of July 25, 2025, and represents a non-set-aside competitive procurement. The award was issued from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,417.46 for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. Issued on August 5, 2025, with completion targeted for August 6, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement under a competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,847.34 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used in the treatment of chronic obstructive pulmonary disease. This firm fixed price delivery order, issued on August 5, 2025, represents a single transaction under a larger contract vehicle. The award was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $1,637.52 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The award was made on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a firm fixed price, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a Delivery Order valued at $16,547.64 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder used for chronic obstructive pulmonary disease management. The competitively awarded contract, which was not set aside for any specific business category, is firm fixed price and was executed on September 11, 2025, with an ultimate completion date of September 12, 2025. The product will be performed and delivered from...
- The Defense Logistics Agency awarded a delivery order valued at $10,024.03 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used for chronic obstructive pulmonary disease management. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,801.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This non-set-aside competitive award is scheduled for completion by August 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value...
- The Defense Logistics Agency (DLA) awarded a $11,398.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). The product...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYWGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,609.36 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, issued on August 26, 2025, represents a non-competitive award under the company's existing contract vehicle and is scheduled for completion by August 27, 2025. Performance will be conducted at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as the primary pharmaceutical supply vehicle for the Defense Health Agency and military healthcare systems, enabling the delivery of a comprehensive range of medications, vaccines, medical supplies, and specialty pharmaceuticals to support federal medical procurement needs globally. AmerisourceBergen's continued role as a critical federal pharmaceutical distributor reflects its capability to meet the complex supply chain requirements of the Department of Defense medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 8/26/25 |